泰凌医药（股票代码：01011）于2026年6月1日发布了截至2026年5月31日的股份变动月报。公告显示，公司普通股注册股数为62,592,500,000股，每股面值0.0000008美元，注册股本约为USD 50,074；优先股注册股数为32,500,000股，每股面值0.0000008美元，注册股本约为USD 26。截至5月底，公司股本总额约USD 50,100，普通股已发行股份（不含库存股份）为948,997,694股，与上月保持一致。
当月内公司未发生新增发行、购回或注销等股份变动，也无任何其它股份或股权激励计划的增减事宜，整体股本保持稳定。公司表示已遵守香港联合交易所有限公司《上市规则》及相关法律规定，本公告由执行董事吴铁签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.